Form 8-K Kinnate Biopharma Inc. For: Jan 09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Oil prices jump 4% as fresh US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Dell again lifts annual forecasts as AI demand powers record results
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- Gap taps Coach architect Reed Krakoff for $29.95-$498 handbag line
- Comstock Resources signs $1.65B deal with SOCAR, $450M JV
Kinnate Biopharma (KNTE) to Cut 56% Staff
January 16, 2024 4:08 PM ESTOn January 9, 2024, Kinnate Biopharma (NASDAQ: KNTE) committed to implement a further workforce reduction (the RIF) pursuant to which the Company will reduce its workforce by approximately 56% to a total of 12 remaining full-time employees. The RIF is being implemented in connection with a process the Company... More
